Concepedia

Joseph M. Gozgit

JM

Statistics

Publications

19

Citations

2.2K

H-Index

16

Active since

2004

Affiliations

Ariadne Diagnostics (United States)(Current)

University of Massachusetts Amherst

Wadsworth Center

Baystate Medical Center

New York State Department of Health

Joseph M. Gozgit is an author at Ariadne Diagnostics (United States) specializing in medicine, oncology, and molecular oncology.

Publications per year

2004–2021

19

Publications

19

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Michael Hedvat, Dennis Huszar, Andreas Herrmann et al. · Cancer Cell · 2009 · 529 citations · Full text

, , +9

Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models

Joseph M. Gozgit, Matthew J. Wong, Lauren Moran et al. · Molecular Cancer Therapeutics · 2012 · 321 citations · Full text

, , +12

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

Joseph M. Gozgit, Melissa M. Vasbinder, Ryan Abo et al. · Cancer Cell · 2021 · 183 citations

, , +14

Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients

Andrew P. Garner, Joseph M. Gozgit, Rana Anjum et al. · Clinical Cancer Research · 2014 · 160 citations

, , +15

Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies

Joseph M. Gozgit, Matthew J. Wong, Scott Wardwell et al. · Molecular Cancer Therapeutics · 2011 · 152 citations · Full text

, , +17

1–5 of 19